Bone Biologics: Funding, Investors & Team (Sep 2026)
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the development and promotion of orthobiologic products. The company's main focus is on NELL-1, a proprietary platform technology consisting of a synthetic human protein growth factor crucial for the proper development of bones.
Bone Biologics has raised $10.1M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Jun 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bone Biologics Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Bone Biologics Funding Rounds
Bone Biologics raised $5.1M in a Post-IPO Equity announced in Oct 2022.
2.7 years later, an undisclosed round of $5.0M was announced in Jun 2025.
Bone Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Bone Biologics Funding Compared to Other Biotechnology Startups
Bone Biologics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bone Biologics in Biotechnology and Burlington
Companies Similar to Bone Biologics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Bone Biologics Funding FAQs
What does Bone Biologics do?
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the development and promotion of orthobiologic products. The company's main focus is on NELL-1, a proprietary platform technology consisting of a synthetic human protein growth factor crucial for the proper development of bones.
How much funding has Bone Biologics raised?
Bone Biologics has raised $10.1M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Jun 2025.
When did Bone Biologics last raise funding?
Bone Biologics' most recent funding round on record is an undisclosed round of $5.0M, announced in Jun 2025.
Who founded Bone Biologics?
FundedIQ lists Michael Schuler (Founder) at Bone Biologics.
Where is Bone Biologics headquartered?
Bone Biologics is based in Burlington, Massachusetts, United States.
How many employees does Bone Biologics have?
Bone Biologics is in the 11-50 employee band.
How does Bone Biologics' funding compare to other Biotechnology startups?
Bone Biologics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Bone Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bone Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.